Source: International Congress 2019 – Physiology of cystic fibrosis
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Gaupmann (Vienna, Austria), S. Gruber (Vienna, Austria), L. Gona-Hoepler (Vienna, Austria), E. Nachbaur (Vienna, Austria), Z. Szepfalusi (Vienna, Austria), S. Renner (Vienna, Austria), E. Dehlink (Vienna, Austria). Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection. 346

Member's Comments

No comment yet.

Related content which might interest you: Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 685s Year: 2005 Efficacy of non-invasive positive pressure ventilation (NIPPV) in cystic fibrosis (CF) patients with acute respiratory failure (ARF) Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 Noninvasive positive pressure ventilation in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches Year: 2006 PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Interstitial pressure and lung oedema in chronic hypoxia Source: Eur Respir J 2011; 37: 943-949 Year: 2011 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 The role of noninvasive positive pressure ventilation (NPPV) in the management of acute respiratory failure in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 278s Year: 2002 Noninvasive ventilation cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=127 Year: 2006 Noninvasive positive pressure ventilation (NPPV) in patients with chronic obstructive pulmonary disease (COPD): effect on the spontaneous PaCO2 and correlation between ventilator pressure and spontaneous PaCO2 Source: Eur Respir J 2001; 18: Suppl. 33, 401s Year: 2001 Relationship of airway dimensions with lung volumes in chronic obstrucive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 655s Year: 2006 Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Source: Eur Respir J 2012; 40: 61-66 Year: 2012 Changes of alveolar oxygen tension in chronic obstructive pulmonary disease (COPD) and effect of variable oxygen tension on hypoxia inducible factor (HIF)-1alpha system of alveolar epithelial cells Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012 Sustained maximum inspiratory pressure in patients with cystic fibrosis and severe airway obstruction Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013